Skip to search formSkip to main contentSkip to account menu

nilvadipine

Known as: 3,5-Pyridinedicarboxylic acid, 2-cyano-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-, 3-methyl 5-(1-methylethyl) ester 
National Institutes of Health

Related topics

Related topics

7 relations

Broader (3)

Antihypertensive AgentsCalcium Channel BlockersNifedipine

Narrower (3)

EscorFR 34235Nivadil
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Five different profiles of dihydropyridines in blocking T-type Ca(2+) channel subtypes (Ca(v)3.1 (alpha(1G)), Ca(v)3.2 (alpha(1H)), and Ca(v)3.3 (alpha(1I))) expressed in Xenopus oocytes.
2008
2008
Retinal Concentration and Protective Effect against Retinal Ischemia of Nilvadipine in Rats
Purpose Several calcium entry blockers have neuroprotective effects on cellular damage in the brain induced by ischemia. The… 
Highly Cited
2003
Highly Cited
2003
Uniformly sized molecularly imprinted polymer for (S)-nilvadipine. Comparison of chiral recognition ability with HPLC chiral stationary phases based on a protein.
Uniformly sized molecularly imprinted polymers (MIPs) for (S)-nilvadipine have been prepared by a multistep swelling and… 
Highly Cited
2002
Highly Cited
2002
Preservation of retinal morphology and functions in royal college surgeons rat by nilvadipine, a Ca(2+) antagonist.
PURPOSE The Royal College of Surgeons (RCS) rat is the most extensively studied animal model for understanding the molecular… 
1999
1999
Different effects of L-type and T-type calcium channel blockers on the hypnotic potency of triazolam and zolpidem in rats
1991
1991
Attenuated neuropathology by nilvadipine after middle cerebral artery occlusion in rats.
We investigated the effects of nilvadipine, a calcium antagonist, on cerebral ischemia in rats. Under halothane anesthesia, 30… 
Review
1988
Review
1988
Induction of plasma and tissue enzymes by drugs: significance in toxicological studies.
1. Observations of drug metabolism enzyme induction in animals during early toxicological trials, and phase I or II of clinical… 
1987
1987
Determination of (+)- and (-)-nilvadipine in human plasma using chiral stationary-phase liquid chromatography and gas chromatography-mass spectrometry, and a preliminary pharmacokinetic study in…
A stereoselective and sensitive method for the determination of nilvadipine, a new dihydropyridine calcium antagonist, in human… 
1987
1987
Pharmacokinetics of Nilvadipine in Healthy Volunteers
The pharmacokinetics of nilvadipine, a new antihypertensive and antianginal drug, were examined in healthy male volunteers. In a… 
1986
1986
Structural studies of a new dihydropyridine calcium channel antagonist, nilvadipine.
The crystal and molecular structure of nilvadipine, 5-isopropyl-3-methyl-2-cyano-6-methyl-4-(3-nitrophenyl)-1, 4-dihydro-3, 5… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)